Pre-Menstrual Syndrome Market - Global Outlook and Forecast 2024-2031

Report ID: 1566691 | Published Date: Feb 2026 | No. of Page: 66 | Base Year: 2025 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Introduction to Research & Analysis Reports
    1.1 Pre-Menstrual Syndrome Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Pre-Menstrual Syndrome Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Pre-Menstrual Syndrome Overall Market Size
    2.1 Global Pre-Menstrual Syndrome Market Size: 2021 VS 2028
    2.2 Global Pre-Menstrual Syndrome Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Pre-Menstrual Syndrome Players in Global Market
    3.2 Top Global Pre-Menstrual Syndrome Companies Ranked by Revenue
    3.3 Global Pre-Menstrual Syndrome Revenue by Companies
    3.4 Top 3 and Top 5 Pre-Menstrual Syndrome Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Pre-Menstrual Syndrome Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Pre-Menstrual Syndrome Players in Global Market
        3.6.1 List of Global Tier 1 Pre-Menstrual Syndrome Companies
        3.6.2 List of Global Tier 2 and Tier 3 Pre-Menstrual Syndrome Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Pre-Menstrual Syndrome Market Size Markets, 2021 & 2028
        4.1.2 Analgesics (Pain Killers)
        4.1.3 Oral Contraceptive Pills (OCPs)
        4.1.4 Gonadotropin-Releasing Hormone (GnRH)
        4.1.5 Antidepressants
        4.1.6 Ovarian Suppressors
        4.1.7 Diuretics
        4.1.8 Benzodiazepines
    4.2 By Type - Global Pre-Menstrual Syndrome Revenue & Forecasts
        4.2.1 By Type - Global Pre-Menstrual Syndrome Revenue, 2017-2022
        4.2.2 By Type - Global Pre-Menstrual Syndrome Revenue, 2023-2028
        4.2.3 By Type - Global Pre-Menstrual Syndrome Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Pre-Menstrual Syndrome Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinic
        5.1.4 Others
    5.2 By Application - Global Pre-Menstrual Syndrome Revenue & Forecasts
        5.2.1 By Application - Global Pre-Menstrual Syndrome Revenue, 2017-2022
        5.2.2 By Application - Global Pre-Menstrual Syndrome Revenue, 2023-2028
        5.2.3 By Application - Global Pre-Menstrual Syndrome Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Pre-Menstrual Syndrome Market Size, 2021 & 2028
    6.2 By Region - Global Pre-Menstrual Syndrome Revenue & Forecasts
        6.2.1 By Region - Global Pre-Menstrual Syndrome Revenue, 2017-2022
        6.2.2 By Region - Global Pre-Menstrual Syndrome Revenue, 2023-2028
        6.2.3 By Region - Global Pre-Menstrual Syndrome Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Pre-Menstrual Syndrome Revenue, 2017-2028
        6.3.2 US Pre-Menstrual Syndrome Market Size, 2017-2028
        6.3.3 Canada Pre-Menstrual Syndrome Market Size, 2017-2028
        6.3.4 Mexico Pre-Menstrual Syndrome Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Pre-Menstrual Syndrome Revenue, 2017-2028
        6.4.2 Germany Pre-Menstrual Syndrome Market Size, 2017-2028
        6.4.3 France Pre-Menstrual Syndrome Market Size, 2017-2028
        6.4.4 U.K. Pre-Menstrual Syndrome Market Size, 2017-2028
        6.4.5 Italy Pre-Menstrual Syndrome Market Size, 2017-2028
        6.4.6 Russia Pre-Menstrual Syndrome Market Size, 2017-2028
        6.4.7 Nordic Countries Pre-Menstrual Syndrome Market Size, 2017-2028
        6.4.8 Benelux Pre-Menstrual Syndrome Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Pre-Menstrual Syndrome Revenue, 2017-2028
        6.5.2 China Pre-Menstrual Syndrome Market Size, 2017-2028
        6.5.3 Japan Pre-Menstrual Syndrome Market Size, 2017-2028
        6.5.4 South Korea Pre-Menstrual Syndrome Market Size, 2017-2028
        6.5.5 Southeast Asia Pre-Menstrual Syndrome Market Size, 2017-2028
        6.5.6 India Pre-Menstrual Syndrome Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Pre-Menstrual Syndrome Revenue, 2017-2028
        6.6.2 Brazil Pre-Menstrual Syndrome Market Size, 2017-2028
        6.6.3 Argentina Pre-Menstrual Syndrome Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Pre-Menstrual Syndrome Revenue, 2017-2028
        6.7.2 Turkey Pre-Menstrual Syndrome Market Size, 2017-2028
        6.7.3 Israel Pre-Menstrual Syndrome Market Size, 2017-2028
        6.7.4 Saudi Arabia Pre-Menstrual Syndrome Market Size, 2017-2028
        6.7.5 UAE Pre-Menstrual Syndrome Market Size, 2017-2028
7 Players Profiles
    7.1 Alva-Amco Pharmacal Cos., Inc.
        7.1.1 Alva-Amco Pharmacal Cos., Inc. Corporate Summary
        7.1.2 Alva-Amco Pharmacal Cos., Inc. Business Overview
        7.1.3 Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Major Product Offerings
        7.1.4 Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
        7.1.5 Alva-Amco Pharmacal Cos., Inc. Key News
    7.2 Bayer, Inc.
        7.2.1 Bayer, Inc. Corporate Summary
        7.2.2 Bayer, Inc. Business Overview
        7.2.3 Bayer, Inc. Pre-Menstrual Syndrome Major Product Offerings
        7.2.4 Bayer, Inc. Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
        7.2.5 Bayer, Inc. Key News
    7.3 Chattem, Inc. (Sanofi)
        7.3.1 Chattem, Inc. (Sanofi) Corporate Summary
        7.3.2 Chattem, Inc. (Sanofi) Business Overview
        7.3.3 Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Major Product Offerings
        7.3.4 Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
        7.3.5 Chattem, Inc. (Sanofi) Key News
    7.4 DEKK-TEC, Inc.
        7.4.1 DEKK-TEC, Inc. Corporate Summary
        7.4.2 DEKK-TEC, Inc. Business Overview
        7.4.3 DEKK-TEC, Inc. Pre-Menstrual Syndrome Major Product Offerings
        7.4.4 DEKK-TEC, Inc. Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
        7.4.5 DEKK-TEC, Inc. Key News
    7.5 G. R. Lane Health Products Ltd
        7.5.1 G. R. Lane Health Products Ltd Corporate Summary
        7.5.2 G. R. Lane Health Products Ltd Business Overview
        7.5.3 G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Major Product Offerings
        7.5.4 G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
        7.5.5 G. R. Lane Health Products Ltd Key News
    7.6 McNeil Consumer Healthcare
        7.6.1 McNeil Consumer Healthcare Corporate Summary
        7.6.2 McNeil Consumer Healthcare Business Overview
        7.6.3 McNeil Consumer Healthcare Pre-Menstrual Syndrome Major Product Offerings
        7.6.4 McNeil Consumer Healthcare Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
        7.6.5 McNeil Consumer Healthcare Key News
    7.7 MetP Pharma AG
        7.7.1 MetP Pharma AG Corporate Summary
        7.7.2 MetP Pharma AG Business Overview
        7.7.3 MetP Pharma AG Pre-Menstrual Syndrome Major Product Offerings
        7.7.4 MetP Pharma AG Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
        7.7.5 MetP Pharma AG Key News
    7.8 Pherin Pharmaceuticals, Inc.
        7.8.1 Pherin Pharmaceuticals, Inc. Corporate Summary
        7.8.2 Pherin Pharmaceuticals, Inc. Business Overview
        7.8.3 Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Major Product Offerings
        7.8.4 Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
        7.8.5 Pherin Pharmaceuticals, Inc. Key News
    7.9 Umecrine Mood AB
        7.9.1 Umecrine Mood AB Corporate Summary
        7.9.2 Umecrine Mood AB Business Overview
        7.9.3 Umecrine Mood AB Pre-Menstrual Syndrome Major Product Offerings
        7.9.4 Umecrine Mood AB Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
        7.9.5 Umecrine Mood AB Key News
    7.10 Novartis AG
        7.10.1 Novartis AG Corporate Summary
        7.10.2 Novartis AG Business Overview
        7.10.3 Novartis AG Pre-Menstrual Syndrome Major Product Offerings
        7.10.4 Novartis AG Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
        7.10.5 Novartis AG Key News
    7.11 GlaxoSmithKline Plc
        7.11.1 GlaxoSmithKline Plc Corporate Summary
        7.11.2 GlaxoSmithKline Plc Business Overview
        7.11.3 GlaxoSmithKline Plc Pre-Menstrual Syndrome Major Product Offerings
        7.11.4 GlaxoSmithKline Plc Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
        7.11.5 GlaxoSmithKline Plc Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Pre-Menstrual Syndrome Market Opportunities & Trends in Global Market
    Table 2. Pre-Menstrual Syndrome Market Drivers in Global Market
    Table 3. Pre-Menstrual Syndrome Market Restraints in Global Market
    Table 4. Key Players of Pre-Menstrual Syndrome in Global Market
    Table 5. Top Pre-Menstrual Syndrome Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Pre-Menstrual Syndrome Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Pre-Menstrual Syndrome Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Pre-Menstrual Syndrome Product Type
    Table 9. List of Global Tier 1 Pre-Menstrual Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Pre-Menstrual Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Pre-Menstrual Syndrome Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Pre-Menstrual Syndrome Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Pre-Menstrual Syndrome Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Pre-Menstrual Syndrome Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Pre-Menstrual Syndrome Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Pre-Menstrual Syndrome Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Pre-Menstrual Syndrome Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Pre-Menstrual Syndrome Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Pre-Menstrual Syndrome Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Pre-Menstrual Syndrome Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Pre-Menstrual Syndrome Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Pre-Menstrual Syndrome Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Pre-Menstrual Syndrome Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Pre-Menstrual Syndrome Revenue, (US$, Mn), 2023-2028
    Table 30. Alva-Amco Pharmacal Cos., Inc. Corporate Summary
    Table 31. Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Product Offerings
    Table 32. Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Revenue (US$, Mn), (2017-2022)
    Table 33. Bayer, Inc. Corporate Summary
    Table 34. Bayer, Inc. Pre-Menstrual Syndrome Product Offerings
    Table 35. Bayer, Inc. Pre-Menstrual Syndrome Revenue (US$, Mn), (2017-2022)
    Table 36. Chattem, Inc. (Sanofi) Corporate Summary
    Table 37. Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Product Offerings
    Table 38. Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Revenue (US$, Mn), (2017-2022)
    Table 39. DEKK-TEC, Inc. Corporate Summary
    Table 40. DEKK-TEC, Inc. Pre-Menstrual Syndrome Product Offerings
    Table 41. DEKK-TEC, Inc. Pre-Menstrual Syndrome Revenue (US$, Mn), (2017-2022)
    Table 42. G. R. Lane Health Products Ltd Corporate Summary
    Table 43. G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Product Offerings
    Table 44. G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Revenue (US$, Mn), (2017-2022)
    Table 45. McNeil Consumer Healthcare Corporate Summary
    Table 46. McNeil Consumer Healthcare Pre-Menstrual Syndrome Product Offerings
    Table 47. McNeil Consumer Healthcare Pre-Menstrual Syndrome Revenue (US$, Mn), (2017-2022)
    Table 48. MetP Pharma AG Corporate Summary
    Table 49. MetP Pharma AG Pre-Menstrual Syndrome Product Offerings
    Table 50. MetP Pharma AG Pre-Menstrual Syndrome Revenue (US$, Mn), (2017-2022)
    Table 51. Pherin Pharmaceuticals, Inc. Corporate Summary
    Table 52. Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Product Offerings
    Table 53. Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Revenue (US$, Mn), (2017-2022)
    Table 54. Umecrine Mood AB Corporate Summary
    Table 55. Umecrine Mood AB Pre-Menstrual Syndrome Product Offerings
    Table 56. Umecrine Mood AB Pre-Menstrual Syndrome Revenue (US$, Mn), (2017-2022)
    Table 57. Novartis AG Corporate Summary
    Table 58. Novartis AG Pre-Menstrual Syndrome Product Offerings
    Table 59. Novartis AG Pre-Menstrual Syndrome Revenue (US$, Mn), (2017-2022)
    Table 60. GlaxoSmithKline Plc Corporate Summary
    Table 61. GlaxoSmithKline Plc Pre-Menstrual Syndrome Product Offerings
    Table 62. GlaxoSmithKline Plc Pre-Menstrual Syndrome Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Pre-Menstrual Syndrome Segment by Type in 2021
    Figure 2. Pre-Menstrual Syndrome Segment by Application in 2021
    Figure 3. Global Pre-Menstrual Syndrome Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Pre-Menstrual Syndrome Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Pre-Menstrual Syndrome Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Pre-Menstrual Syndrome Revenue in 2021
    Figure 8. By Type - Global Pre-Menstrual Syndrome Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Pre-Menstrual Syndrome Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Pre-Menstrual Syndrome Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Pre-Menstrual Syndrome Revenue Market Share, 2017-2028
    Figure 12. US Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Pre-Menstrual Syndrome Revenue Market Share, 2017-2028
    Figure 16. Germany Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 17. France Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Pre-Menstrual Syndrome Revenue Market Share, 2017-2028
    Figure 24. China Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 28. India Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Pre-Menstrual Syndrome Revenue Market Share, 2017-2028
    Figure 30. Brazil Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Pre-Menstrual Syndrome Revenue Market Share, 2017-2028
    Figure 33. Turkey Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Pre-Menstrual Syndrome Revenue, (US$, Mn), 2017-2028
    Figure 37. Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Bayer, Inc. Pre-Menstrual Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. DEKK-TEC, Inc. Pre-Menstrual Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. McNeil Consumer Healthcare Pre-Menstrual Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. MetP Pharma AG Pre-Menstrual Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Umecrine Mood AB Pre-Menstrual Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Novartis AG Pre-Menstrual Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. GlaxoSmithKline Plc Pre-Menstrual Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
66
Frequently Asked Questions
Pre-Menstrual Syndrome Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pre-Menstrual Syndrome Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pre-Menstrual Syndrome Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports